Related Experiment Video
Updated: May 22, 2026
13:35
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
[Aging and body composition: the sarcopenic obesity in Spain]
A Gómez-Cabello1, G Vicente Rodríguez, S Vila-Maldonado
1Grupo de Investigación GENUD (Growth, Exercise, Nutrition and Development) Zaragoza, Universidad de Zaragoza, Zaragoza, España.
Nutricion Hospitalaria
|May 9, 2012
Summary
Sarcopenic obesity, characterized by excess body fat and muscle loss, affects 15% of non-institutionalized seniors in Spain. This condition in older adults is linked to decreased quality of life and increased mortality risk.
Area of Science:
- Gerontology and human aging.
- Body composition and age-related changes.
Context:
- Global increase in life expectancy leading to a larger elderly population.
- By 2050, one-third of the Spanish population will be over 65.
- Aging is associated with increased fat mass, decreased muscle mass, and reduced bone mass.
Purpose:
- To define and assess the prevalence of sarcopenic obesity in non-institutionalized Spanish seniors.
- To understand the implications of age-related body composition changes.
Summary:
- Sarcopenic obesity is defined as the simultaneous presence of excess body fat and significant muscle mass loss.
- The elderly EXERNET multi-centre study revealed a 15% prevalence of sarcopenic obesity in Spanish seniors.
- These body composition changes contribute to health issues like obesity, sarcopenia, and osteoporosis.
Impact:
- Highlights a significant health concern in the aging Spanish population.
- Sarcopenic obesity can decrease quality of life, increase dependence, and raise mortality risk in seniors.
- Provides crucial data for developing targeted interventions for elderly health and well-being.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:09Changes in the Appendicular Skeleton with Age
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...